메뉴 건너뛰기




Volumn 46, Issue 8, 1997, Pages 930-934

Effects of heparin treatment on hemostatic abnormalities in obese non- insulin-dependent diabetic patients

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7; FIBRINOGEN; HEPARIN; PROTHROMBIN; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0030855546     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(97)90082-2     Document Type: Article
Times cited : (5)

References (38)
  • 1
  • 2
    • 0024996265 scopus 로고
    • Diabetes, fibrinogen and risk of cardiovascular disease: The Framingham experience
    • Kannel WB, D'Agostino RB, Wilson PW, et al: Diabetes, fibrinogen and risk of cardiovascular disease: The Framingham experience. Am Heart J 120:672-676, 1990
    • (1990) Am Heart J , vol.120 , pp. 672-676
    • Kannel, W.B.1    D'Agostino, R.B.2    Wilson, P.W.3
  • 3
    • 0022591979 scopus 로고
    • The pathogenesis of atherosclerosis: An update
    • Ross R: The pathogenesis of atherosclerosis: An update. N Engl J Med 14:488-500, 1986
    • (1986) N Engl J Med , vol.14 , pp. 488-500
    • Ross, R.1
  • 4
    • 0027119951 scopus 로고
    • Thrombosis and atherogenesis: Molecular connections
    • Nachman RL: Thrombosis and atherogenesis: Molecular connections. Blood 79:1897-1906, 1992
    • (1992) Blood , vol.79 , pp. 1897-1906
    • Nachman, R.L.1
  • 5
    • 0023270863 scopus 로고
    • Diabetes mellitus as a hypercoagulable state: Its relationships with fibrin fragments and vascular damage
    • Garcia Frade LJ, de la Calle H, Alava I, et al: Diabetes mellitus as a hypercoagulable state: Its relationships with fibrin fragments and vascular damage. Thromb Res 47:533-540, 1987
    • (1987) Thromb Res , vol.47 , pp. 533-540
    • Garcia Frade, L.J.1    De La Calle, H.2    Alava, I.3
  • 6
    • 0023855392 scopus 로고
    • Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus
    • Auwerx J, Bouillon R, Collen D, et al: Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus. Arteriosclerosis 8:68-72, 1988
    • (1988) Arteriosclerosis , vol.8 , pp. 68-72
    • Auwerx, J.1    Bouillon, R.2    Collen, D.3
  • 7
    • 0026569276 scopus 로고
    • Effect of diabetes on the coagulation and fibrinolytic systems and its implications for atherogenesis
    • Schneider DJ, Sobel BE: Effect of diabetes on the coagulation and fibrinolytic systems and its implications for atherogenesis. Coron Artery Dis 3:26-32, 1992
    • (1992) Coron Artery Dis , vol.3 , pp. 26-32
    • Schneider, D.J.1    Sobel, B.E.2
  • 8
    • 0026480611 scopus 로고
    • Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus
    • Carmassi F, Morale M, Puccetti R, et al: Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus. Thromb Res 67:643-654, 1992
    • (1992) Thromb Res , vol.67 , pp. 643-654
    • Carmassi, F.1    Morale, M.2    Puccetti, R.3
  • 9
    • 0025976627 scopus 로고
    • Insulin resistance and compensatory hyperinsulinia; Role in hypertension, dyslipidemia and coronary heart disease
    • Reaven GM: Insulin resistance and compensatory hyperinsulinia; Role in hypertension, dyslipidemia and coronary heart disease. Am Heart J 121:1283-1288, 1991
    • (1991) Am Heart J , vol.121 , pp. 1283-1288
    • Reaven, G.M.1
  • 10
    • 0020319478 scopus 로고
    • Insulin secretion, insulin resistance and obesity
    • De Fronzo RA: Insulin secretion, insulin resistance and obesity. Int J Obes 6:73-82, 1982
    • (1982) Int J Obes , vol.6 , pp. 73-82
    • De Fronzo, R.A.1
  • 11
    • 0028008336 scopus 로고
    • Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients
    • McGill JB, Schneider DJ, Arfken CL, et al: Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients. Diabetes 43:104-109, 1994
    • (1994) Diabetes , vol.43 , pp. 104-109
    • McGill, J.B.1    Schneider, D.J.2    Arfken, C.L.3
  • 12
    • 0028334510 scopus 로고
    • Evaluation of cardiovascular risk factors in overweight and obese subjects
    • Avellone G, Di Garbo V, Cordova R, et al: Evaluation of cardiovascular risk factors in overweight and obese subjects. Int Angiol 13:25-29, 1994
    • (1994) Int Angiol , vol.13 , pp. 25-29
    • Avellone, G.1    Di Garbo, V.2    Cordova, R.3
  • 13
    • 0003514455 scopus 로고
    • Report of a WHO study group
    • Geneva, Switzerland
    • World Health Organization Expert Committee on Diabetes Mellitus: Report of a WHO study group. Geneva, Switzerland, WHO Tech Rep Ser 727, 1985
    • (1985) WHO Tech Rep Ser , vol.727
  • 15
    • 0021210911 scopus 로고
    • Fibrinogen as risk factor for stroke and myocardial infarction
    • Wilhelmsen L. Svardsudd K, Korsan-Bengtsen K, et al: Fibrinogen as risk factor for stroke and myocardial infarction. N Engl J Med 311:501-505, 1984
    • (1984) N Engl J Med , vol.311 , pp. 501-505
    • Wilhelmsen, L.1    Svardsudd, K.2    Korsan-Bengtsen, K.3
  • 16
    • 0022485106 scopus 로고
    • Haemostatic function and ischaemic heart disease: Principal results of the Northwick Park Heart Study
    • Meade TW, Mellows S, Brozovic M, et al: Haemostatic function and ischaemic heart disease: Principal results of the Northwick Park Heart Study. Lancet 11:533-537, 1986
    • (1986) Lancet , vol.11 , pp. 533-537
    • Meade, T.W.1    Mellows, S.2    Brozovic, M.3
  • 17
    • 0025827323 scopus 로고
    • Tissue type plasminogen tivator binds to and is inhibited by surface-bound Lp(a) and LDL
    • Simon DI, Fless GM, Scanu AM, et al: Tissue type plasminogen tivator binds to and is inhibited by surface-bound Lp(a) and LDL. Biochemistry 30:6671-6677, 1991
    • (1991) Biochemistry , vol.30 , pp. 6671-6677
    • Simon, D.I.1    Fless, G.M.2    Scanu, A.M.3
  • 18
    • 0027195040 scopus 로고
    • Fibrinolysis in hypertriglyceridaemic subjects in response to venous occlusion
    • Avellone G, Di Garbo V, Cordova R, et al: Fibrinolysis in hypertriglyceridaemic subjects in response to venous occlusion. Blood Coagul Fibrinol 4:429-433, 1993
    • (1993) Blood Coagul Fibrinol , vol.4 , pp. 429-433
    • Avellone, G.1    Di Garbo, V.2    Cordova, R.3
  • 19
    • 0022354051 scopus 로고
    • Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction
    • Hamsten A, Wiman B, De Faire U, et al: Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 313:1557-1563, 1985
    • (1985) N Engl J Med , vol.313 , pp. 1557-1563
    • Hamsten, A.1    Wiman, B.2    De Faire, U.3
  • 20
    • 0025970133 scopus 로고
    • Evidence for increased levels of plasminogen activator inhibitors and tissue plasminogen activator in plasma in patients with angiographically verified coronary artery disease
    • Olofsson BO, Dahlen G, Nilsson TK: Evidence for increased levels of plasminogen activator inhibitors and tissue plasminogen activator in plasma in patients with angiographically verified coronary artery disease. Eur Heart J 12:157-161, 1991
    • (1991) Eur Heart J , vol.12 , pp. 157-161
    • Olofsson, B.O.1    Dahlen, G.2    Nilsson, T.K.3
  • 21
    • 0025734531 scopus 로고
    • Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherogenesis
    • Juhan-Vague I, Alessi MC, Vague P: Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherogenesis. Diabetologia 34:457-462, 1991
    • (1991) Diabetologia , vol.34 , pp. 457-462
    • Juhan-Vague, I.1    Alessi, M.C.2    Vague, P.3
  • 22
    • 0025941333 scopus 로고
    • Hyperinsulinemia, sex, and risk of atherosclerotic cardiovascular disease
    • Modan M, Or J, Karasik A, et al: Hyperinsulinemia, sex, and risk of atherosclerotic cardiovascular disease. Circulation 84:1165-1175, 1991
    • (1991) Circulation , vol.84 , pp. 1165-1175
    • Modan, M.1    Or, J.2    Karasik, A.3
  • 23
    • 0027463873 scopus 로고
    • Plasminogen activator inhibitor activity in diabetic and nondiabetic survivors of myocardial infarction
    • Gray RP, Patterson DLH, Yudkin JS: Plasminogen activator inhibitor activity in diabetic and nondiabetic survivors of myocardial infarction. Arterioscler Thromb 13:415-420, 1993
    • (1993) Arterioscler Thromb , vol.13 , pp. 415-420
    • Gray, R.P.1    Patterson, D.L.H.2    Yudkin, J.S.3
  • 24
    • 0020536979 scopus 로고
    • Hypertriglyceridaemia and hypercoagulability
    • Simpson HCR, Meade TW, Stirling Y, et al: Hypertriglyceridaemia and hypercoagulability. Lancet 1:786-790, 1983
    • (1983) Lancet , vol.1 , pp. 786-790
    • Simpson, H.C.R.1    Meade, T.W.2    Stirling, Y.3
  • 25
    • 0026567090 scopus 로고
    • Hypertriglyceridemia and regulation of fibrinolytic activity
    • Mussoni L, Mannucci L, Sirtori M, et al: Hypertriglyceridemia and regulation of fibrinolytic activity. Arterioscler Thromb 12:19-27, 1992
    • (1992) Arterioscler Thromb , vol.12 , pp. 19-27
    • Mussoni, L.1    Mannucci, L.2    Sirtori, M.3
  • 26
    • 0023801759 scopus 로고
    • Association between coagulation factor VII and X with triglyceride rich lipoproteins
    • Carvalho de Sousa J, Soria C, Ayrault-Jarret M, et al: Association between coagulation factor VII and X with triglyceride rich lipoproteins. J Clin Pathol 41:940-944, 1988
    • (1988) J Clin Pathol , vol.41 , pp. 940-944
    • Carvalho De Sousa, J.1    Soria, C.2    Ayrault-Jarret, M.3
  • 27
    • 0026762721 scopus 로고
    • Prospective analysis of the insulin-resistance syndrome (syndrome X)
    • Haffner SM, Valdez RA, Hazuda HP, et al: Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 41:715-722, 1992
    • (1992) Diabetes , vol.41 , pp. 715-722
    • Haffner, S.M.1    Valdez, R.A.2    Hazuda, H.P.3
  • 28
    • 0027978123 scopus 로고
    • Coagulation, lysis and haemorrheology in premenopausal obese women with different body fat distribution
    • Avellone G, Di Garbo V, Cordova R, et al: Coagulation, lysis and haemorrheology in premenopausal obese women with different body fat distribution. Thromb Res 75:223-231, 1994
    • (1994) Thromb Res , vol.75 , pp. 223-231
    • Avellone, G.1    Di Garbo, V.2    Cordova, R.3
  • 29
    • 0029550047 scopus 로고
    • Haemostatic function in young subjects with central obesity: Relationship with left ventricular function
    • Licata G, Scaglione R, Avellone G, et al: Haemostatic function in young subjects with central obesity: Relationship with left ventricular function. Metabolism 44:1417-1421, 1995
    • (1995) Metabolism , vol.44 , pp. 1417-1421
    • Licata, G.1    Scaglione, R.2    Avellone, G.3
  • 30
    • 0022636643 scopus 로고
    • Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors
    • Folsom AR, Wu KK, Davis CE, et al: Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis 59:263-269, 1986
    • (1986) Atherosclerosis , vol.59 , pp. 263-269
    • Folsom, A.R.1    Wu, K.K.2    Davis, C.E.3
  • 31
    • 0022625882 scopus 로고
    • Correlation between blood fibrinolytic activity, plasminogen inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects
    • Vague P, Juhan-Vague I, Allaud MF, et al: Correlation between blood fibrinolytic activity, plasminogen inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects. Metabolism 35:250-253, 1986
    • (1986) Metabolism , vol.35 , pp. 250-253
    • Vague, P.1    Juhan-Vague, I.2    Allaud, M.F.3
  • 32
    • 0028685826 scopus 로고
    • Blood coagulation and fibrinolysis in obese NIDDM patients
    • Avellone G, Di Garbo V, Cordova R, et al: Blood coagulation and fibrinolysis in obese NIDDM patients. Diabetes Res 25:85-92, 1994
    • (1994) Diabetes Res , vol.25 , pp. 85-92
    • Avellone, G.1    Di Garbo, V.2    Cordova, R.3
  • 33
    • 0028321765 scopus 로고
    • Haemostatic abnormalities persist despite glycaemic improvement by insulin therapy in lean type 2 diabetic patients
    • Knobl P, Schenhahaner G, Schnack C, et al: Haemostatic abnormalities persist despite glycaemic improvement by insulin therapy in lean type 2 diabetic patients. Thromb Haemost 71:692-697, 1994
    • (1994) Thromb Haemost , vol.71 , pp. 692-697
    • Knobl, P.1    Schenhahaner, G.2    Schnack, C.3
  • 34
    • 0030055521 scopus 로고    scopus 로고
    • Influence of metabolic control on thromboxane biosynthesis and plasma plasminogen activator inhibitor type-1 in non-insulin-dependent diabetes mellitus
    • Davi G, Belvedere M, Vigneri S, et al: Influence of metabolic control on thromboxane biosynthesis and plasma plasminogen activator inhibitor type-1 in non-insulin-dependent diabetes mellitus. Thromb Haemost 76:34-37, 1996
    • (1996) Thromb Haemost , vol.76 , pp. 34-37
    • Davi, G.1    Belvedere, M.2    Vigneri, S.3
  • 35
    • 0023092605 scopus 로고
    • Effectiveness of low-dose heparin in prevention of myocardial reinfarction
    • Neri Serneri GG, Gensini GF, Carnovali M et al: Effectiveness of low-dose heparin in prevention of myocardial reinfarction. Lancet 1:937-942, 1987
    • (1987) Lancet , vol.1 , pp. 937-942
    • Neri Serneri, G.G.1    Gensini, G.F.2    Carnovali, M.3
  • 36
    • 0024819693 scopus 로고
    • Hyperglycemia may determine fibrinopeptide A plasma level increase in humans
    • Ceriello A, Giugliano D, Quatraro A, et al: Hyperglycemia may determine fibrinopeptide A plasma level increase in humans. Metabolism 38:1162-1163, 1989
    • (1989) Metabolism , vol.38 , pp. 1162-1163
    • Ceriello, A.1    Giugliano, D.2    Quatraro, A.3
  • 37
    • 0028009948 scopus 로고
    • Fibrinogen plasma levels as a marker of thrombin activation in diabetes
    • Ceriello A, Taboga C, Giacomello R, et al: Fibrinogen plasma levels as a marker of thrombin activation in diabetes. Diabetes 43:430-432, 1994
    • (1994) Diabetes , vol.43 , pp. 430-432
    • Ceriello, A.1    Taboga, C.2    Giacomello, R.3
  • 38
    • 0018343895 scopus 로고
    • Reduced fibrinogen survival in diabetes mellitus: A reversible phenomenon
    • Jones RL, Peterson CM: Reduced fibrinogen survival in diabetes mellitus: A reversible phenomenon. J Clin Invest 63:485-493, 1979
    • (1979) J Clin Invest , vol.63 , pp. 485-493
    • Jones, R.L.1    Peterson, C.M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.